Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2
Kiran Shehzadi, Afsheen Saba, Mingjia Yu, et al.
Topics in Current Chemistry (2023) Vol. 381, Iss. 5
Closed Access | Times Cited: 11

Showing 11 citing articles:

The Chiral 5,6-Cyclohexane-fused Uracil Ring-System: a Molecular Platform with Promising Activity against SARS-CoV-2
Enrico Marcantonio, Debora Guazzetti, Crescenzo Coppa, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117302-117302
Closed Access
Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle
Mingzhenlong Deng, Chuang Zhang, Wanli Yan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2850-2850
Open Access | Times Cited: 4
New perspective of small-molecule antiviral drugs development for RNA viruses
Shasha Li, Huixia Li, Ruiya Lian, et al.
Virology (2024) Vol. 594, pp. 110042-110042
Closed Access | Times Cited: 4
Recent Advancements in the Therapeutic Development for Marburg Virus: Updates on Clinical Trials
Garima Sharma, Ashish Ranjan Sharma, Jin‐Chul Kim
Current Infectious Disease Reports (2024) Vol. 26, Iss. 2, pp. 57-67
Closed Access | Times Cited: 3
Innovative Molecularly Imprinted Electrochemical Sensor for Selective Nanomolar Detection of the Anti-COVID-19 Medication Molnupiravir
Rania A. Sayed, Manal S. Elmasry, Asmaa M. Taha, et al.
Journal of The Electrochemical Society (2024) Vol. 171, Iss. 6, pp. 067507-067507
Closed Access | Times Cited: 3
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 2
Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2
Larysa V. Yevsieieva, Kateryna Lohachova, Alexander Kyrychenko, et al.
RSC Advances (2023) Vol. 13, Iss. 50, pp. 35500-35524
Open Access | Times Cited: 7
De Novo Potent Peptide Nucleic Acid Antisense Oligomer Inhibitors Targeting SARS-CoV-2 RNA-Dependent RNA Polymerase via Structure-Guided Drug Design
Kiran Shehzadi, Mingjia Yu, Jianhua Liang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17473-17473
Open Access | Times Cited: 4
Identification of a New Drug Binding Site in the RNA-Dependent-RNA-Polymerase (RdRp) Domain
Aparna S. Gana, James N. Baraniuk
BioMedInformatics (2023) Vol. 3, Iss. 4, pp. 885-907
Open Access | Times Cited: 2
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors
Xudong Wang, Liwei Xiong, Ying Zhu, et al.
Journal of the American Chemical Society (2024)
Closed Access
Design, synthesis and biological evaluation of biaryl amide derivatives against SARS-CoV-2 with dual-target mechanism
Jiayu Li, Xiuli Zhong, Hongying Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115978-115978
Closed Access
Page 1

Scroll to top